Abstract-Closed-loop neurostimulation has shown great promise as an alternate therapy for over 30% of the epileptic patient population that remain non-responsive to other forms of treatment. We present an event-based seizure detection algorithm that can be implemented in real-time using low power digital CMOS circuits to form an implantable epilepsy prosthesis. Seizures are detected by classifying and marking out 'events' in the recorded local field potential data and measuring the inter-event-intervals (IEI). The circuit implementation can be programmed post-implantation to custom fit the thresholds for detection. Hippocampal depth electrode recordings are used to validate the efficacy of a designed hardware prototype and thresholds are tuned to produce less than 5% false positives from recorded data.
I. INTRODUCTION
Over 50 million people worldwide and a million people in the U.S alone suffer from unpredictable, recurrent seizures. About 30% of this population does not respond to medication or meet eligibility requirements for resective surgery [1] . The possibility of applying electrical stimulation to suppress seizure activity has been reported as early as 1954 by Penfield and colleagues [2] . Vagus nerve stimulation and direct electrical stimulation of the focal tissue have both shown great promise as an alternate therapy for this large patient population. Excessive or continuous neurostimulation, however, has shown to reduce the responsiveness of the neurons to external stimuli, and decreases the efficacy of this therapy [3] . An important aspect to providing on-demand closed-loop stimulation is the design of an efficient seizure detection algorithm that can work in real-time and be feasible in an implantable application. This imposes restrictions on its computational complexity, translating to power consumed in an implant. The algorithm also needs to account for flexibility, allowing for patient-to-patient changes in detection thresholds. Integrating such an algorithm with a neurostimulator is hypothesized to increase the efficiency of this therapy by providing both spatial and temporal selectivity. We describe an implantable algorithm with programmable thresholds that allow the clinician to define the detection events specifically for individual subjects. Animal data was used to verify functional efficacy of a designed hardware prototype with commercially available components in real time. The designed algorithm for detecting seizures is based on 'events'. Moving window averaged amplitude of the recorded filtered local field potential (LFP) data is used to define these events. The distribution of these amplitudes during baseline activity is significantly different from their distribution during a seizure. These differences are used to mark out events and a second block then measures the interval between two marked events to extract frequency indirectly from the LFP data. The interval between two events (IEI) is then compared to a pre-determined 'safe' threshold classify the detected series of events as normal or abnormal. This process is iterated multiple times before a seizure warning flag is raised, indicating that an electrographic seizure has been detected. In the past, the amplitude of neural recordings has been reported to be significantly greater than baseline average due to a constructive interaction of a large number of neurons firing in unison [4] . Seizures are also reported to have an increased power at higher frequencies, attributed to the increased frequency of firing of individual neurons as shown in figure (1) . Combining the IEI parameter with event based detection reduces the probability of false alarms due to isolated high amplitude spikes in the recorded data. Statistical analysis of a set of recorded seizures makes it possible to clearly set thresholds to demarcate baseline from seizure activity.
II. SYSTEM ARCHITECTURE
The detection algorithm is divided into multiple stages of operation that are cascaded in series to raise an alarm when abnormal ictal activity is detected. Band-pass filtered LFP data is first conditioned by linear amplification. Motion artifacts are eliminated by low-pass filtering and DC offsets at the input are removed by capacitive blocking. The conditioned data is then constantly compared to an amplitude threshold, which is updated periodically based on the running average of the recorded data. The threshold detector time-stamps any event over the threshold and feeds this information forward to the IEI extraction block. The time-stamps are taken in succession to calculate the inter-event interval which is compared to a pre-programmed 'safe' threshold. This threshold can be programmed post-implantation and also changed during operation. If the calculated IEI is less than the safe threshold, the stage raises a warning flag to switch on the next stage as shown in figure (2) . The following stage repeats the same functionality over, to look for another occurrence of closely spaced events. If the events are spaced further apart than the safe IEI threshold, then the stage resets and starts the process over again. Each stage added to the chain reduces the probability of false alarms due to isolated bursts of ictal activity, but also increases the processing time needed before a seizure alert is raised. This results in a trade-off between desired sensitivity of the algorithm and response time. We have demonstrated feasibility with a two-stage implementation of the algorithm and quantified its performance with a kainite treated rat model of human temporal lobe epilepsy. 
A. Thresholding and event identification
A critical part of the algorithm design involves threshold fitting and accurate definition of events. The efficacy of the algorithm is defined by the thresholds set. Statistical analysis of recorded baseline and seizure activity from implanted animals revealed clear demarcations in amplitude between the baseline and seizure states. Over 30 seizures were identified and marked out by a combination of visual and electrographic inspection of data/video records by an expert team of neurologists at the Indiana University School of Medicine, Indianapolis, IN. A cumulative distribution plot of recorded baseline activity showed that over 95% of the data amplitudes were under 53µV, averaged over 8 different recordings. The seizure amplitudes were much more widely distributed with the 95% point being roughly 3.5∼4 times greater than the point for baseline activity. The threshold set would have to relate to the baseline average by means of a scaling constant (K) in order to be updated periodically. Optimizing K also presents a trade-off between false-positives and false-negatives of the algorithm. While a low constant would identify a lot more events, increasing the probability of false alarms, a very high constant may cause the system to miss a seizure event.
In the test data-set, a distribution of seizure IEI and baseline IEI was plotted with each chosen scaling constant (K) and the value of K for which the two distributions had minimal overlap was chosen to be used as a threshold. A large animal study is currently underway to relate the value of K to recorded baseline average amplitude for a given individual for optimal performance of the algorithm. This would make it possible to set the thresholds without extensive analysis of recorded seizures from each subject. In this study, the event threshold was set at 2.5 times the baseline average amplitude. This produced an average IEI of 0.134s for seizure activity and about 15.5s for baseline activity. The standard deviations on each distribution were also taken into account when calculating the overlap.
B. Circuit design and simulation
The next step in the design process involved translating the algorithm into hardware in order to test and quantify its efficacy in a real-time application. The primary reason behind avoiding computational complexity was to maintain feasibility as a low power implantable device operating in real-time. The designed algorithm was implemented both in simulation using CMOS circuit blocks operating in an ultralow power mode and also in hardware using commercially available digital components. Figure 3 shows the digital circuit implementation of one stage of the algorithm. The recorded input is conditioned and low-pass filtered to remove motion artifacts. This is then compared to the set amplitude threshold by a comparator which controls the start and stop of a digital binary counter. This counter is clocked by a constant frequency clock oscillator and the amount of time for which the clock feeds the counter is controlled by a toggle-flip flop connected to the comparator. This flip flop keeps the counter ticking for the interval between two events identified by the comparator. Thus, the IEI is digitized and available in binary form. This is then compared to the 'safe' IEI threshold by a digital comparator and a warning flag is raised if it is lower than the threshold. Otherwise, the counter is reset and the process repeated. The architecture of each successive stage is similar to the one described with a few differences in the combinational logic controlling their activation. The advantage of using a modular architecture such as this is the flexibility it providesin terms of power reduction and algorithm efficiency. The stages after the first stage are turned off until the first stage detects an alarm, saving power in a system implementation. This sleep-wake mode of operation was simulated in Cadence using the IBM 130 nm process and results indicated a power consumption of about 140nW for a two stage implementation of the system. It is to be noted that these numbers do not include the op-amp comparator used at the input. Alternately, the op-amp may be replaced with a pseudo digital low power dynamic comparator. The low frequency (under 10 KHz) of operation of the system makes it possible to operate the circuits with an ultra-low supply voltage. Scaling the supply voltage down scales power consumed with a quadratic relationship. The utility of sub-threshold operation of circuits for medical applications is significant given that these devices are mainly constrained by battery size and lifetime [5] . 
III. MATERIALS AND METHODS
A kainic acid (KA) animal model of epilepsy was used to record seizure data from implanted sprague-dawley rats. These animals were injected intraperitonially with 5mg/kg KA hourly until they reached a state of convulsive status epilepticus [6] . LFP recordings (10Hz-500Hz) along with video were obtained during and between each of the 4 injections administered. The treatment was performed 15 days after electrode implantation. Regular baseline data collection was performed prior to KA injection, and periodically to measure changes due to impedance shifts in the recording electrode as a result of the immune response of the tissue. Seizures were marked out by electrographic and visual inspection. Following treatment, one of the animals was perfused using 4% paraformaldehyde in 1X PBS following standard immunohistochemical methods. The immune response of the tissue was clearly observed around the regions of implant and the study also ascertained that the electrode was actually recording LFP data from the vicinity of the hippocampal regions of the animal. (Shown in figure 4) A two stage implementation of the algorithm was prototyped using commercially available components on a printed circuit board. The thresholds were made programmable by using binary switches. The fabricated hardware was tested for noise tolerance. This is critical in an implanted application as the signal being recorded is of the order of a few micro-volts and the signal to noise ratios (SNR) obtained may change over the course of the implant [7] . It was observed that the impedance of the recording tip changed significantly in the first 15 days post implant. In order to simulate these changes, additive white gaussian noise (AWGN) was added to an artificially generated Immunofluorescent GFAP/ED1 double labelled coronal section (100µm thick) through the hippocampus displaying the explanted electrode location relative to dentate gyrus (DG) at 10x magnification.
series of spikes in Matlab and fed into the hardware with varying frequencies and SNR levels.
The number of false detections had a direct relationship with frequency of the spike train and an inverse relationship with SNR. The Matthews correlation co-efficient was used to quantify the efficiency of the system [8] . This returns a number on a scale from -1 to 1, with a score of +1 meaning that the system makes a perfect prediction. In equation 1, TP and TN represent true positives and negatives, and FP and FN represent false positives and negatives respectively.
MCC = (T P × T N) − (F P × F N) (T P + F P )(T P + F N)(T N + F P )(T N + F N)
(1) The two stage prototype hardware had an MCC greater than or equal to 0.96 across frequencies up to 400Hz with an SNR of 3dB or greater. With increasing frequency, the MCC dropped to 0.70 at -5dB SNR and 400Hz. There were less than 3% false positives produced for an SNR of at least 2.2dB for frequencies up to 400Hz. The MCC trend is captured by figure 5 and characterizes the system's noise-frequency performance.
IV. RESULTS AND DISCUSSION
The prototyped two-stage algorithm on the printed circuit board was tested with depth electrode data recorded from the Kainic acid treated animals. Event thresholds were set between 2∼3 times the moving averaged amplitude of the baseline. The IEI threshold was between 0.15∼0.2s on the board. Amplified LFP data was streamed out to the board at the same rate it was recorded to mimic real-time performance. A National Instruments Data acquisition system was used in conjunction with a custom built Matlab GUI, and the outputs of the algorithm were fed back into the acquisition board to be analyzed on the computer. Figure 6b shows a screenshot of the system's response to inter-ictal spikes in one of the recorded data files. Inter-ictal spiking is commonly observed in cases of focal epilepsy but is not indicative of any changes in behavior by itself [9] . The two stage algorithm identifies the spikes, but rejects them as possible seizure alerts. The dotted lines mark out the period of time for which the IEI was measured and the event rejected, as it did not meet the criteria of succession. Figure 6a shows a snapshot of the hardware's response to a more extreme case of spiking-clonic bursting. The clonic part of a seizure usually follows the tonic part, and is characterized by high frequency bursts of activity. These act as an extreme test case for the system. The hardware missed a few bursts due to noise on the input causing the first stage to repeatedly reset. Table 1 summarizes the performance of the two stage prototype with clonic bursting activity. The snapshot in figure  6c shows a larger time window view of an electrographic seizure progressing from baseline activity to seizure state. The hardware detects the onset of the seizure about 2 minutes before the event. Changing the thresholds gives the clinician flexibility of positioning this first detection marker. Since this test did not involve electrical stimulation to suppress detected activity, the alert signal goes off multiple times with higher frequency as it gets closer to the onset. Tuning the thresholds also trades off sensitivity of the algorithm with its efficiency, as discussed earlier. The algorithm was primarily designed with real-time implementation in mind in order to be feasible in an implantable prosthesis. The response time of the circuit was of the order of micro-seconds, but the response time of the algorithm itself is decided by the number of stages in its architecture. Adding stages to the algorithm is analogous to increasing the length of the pipeline in its architecture, increasing the overall latency of the detection. However, with typical electrographic seizures lasting several minutes, addition of a stage does not significantly alter the response time.
V. FUTURE WORK
The discussed algorithm and its hardware implementation open up avenues for integration with an implantable neu- rostimulator to form a closed-loop epilepsy prosthesis. Its computational efficiency makes it possible to implement on silicon using ultra low power circuits, increasing its viability in an implantable application. One of the primary goals of the ongoing large animal trial is to quantitatively describe the threshold fitting process and relate it to baseline measurements for each individual. The study also aims to optimize the number of stages used in detection and present the trade-offs in increasing or decreasing this count. This would increase the efficacy of the algorithm significantly and also provide the clinician with additional flexibility to make changes on a case to case basis.
